Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS LTL, Cheplapharm Envision Heightened Opportunities for LLP Takeovers under Elective Care Scheme
July 16, 2024
-
BUSINESS Meiji Paints Consortium Plan of Its Own, Woos Generic Peers to Join Scheme
July 16, 2024
-
BUSINESS Chiesi Joins Japan Rare Disease Market, Shoots for 10 Billion Yen Sales by 2030
July 12, 2024
-
BUSINESS FY2023 Logs Gyration in COVID Drug Sales, Stark Contrast for Ronapreve, Lagevrio
July 11, 2024
-
REGULATORY Japan Wants to Spur Regulatory Use of RWD, but Still Puts Weight on RCTs
July 10, 2024
-
REGULATORY PMDA to Push Simultaneous Development of Pediatric Drugs via New Consultation Center
July 9, 2024
-
BUSINESS Moderna Medical Chief Voices Excitement for Flu-COVID Jab; Japan PIII Set to Kick Off by Year’s End
July 9, 2024
-
REGULATORY MHLW Proposes New Scheme for Development Requests to Fight Drug Loss
July 8, 2024
-
REGULATORY Panelists Wary of Proposed Switch of Generic GMP Inspection Authority to PMDA
July 8, 2024
-
REGULATORY Minister Nudges Generic Product Consolidation, Pitches “5 Makers per API”
July 5, 2024
-
BUSINESS 32 Pharma Execs Snag 100 Million Yen-Plus in FY2023, Takeda Sweeps Top 3
July 4, 2024
-
BUSINESS Chugai Grabs Japan’s Best-Paying Pharma Crown Yet Again: Jiho Tally
July 3, 2024
-
REGULATORY New ICH Topic on RWD to Be Proposed towards Its Use in Regulatory Review
July 2, 2024
-
REGULATORY PMDA Opens 1st Overseas Office in Bangkok
July 2, 2024
-
BUSINESS Eisai to Go Solo on Its 1st ADC after BMS Exits Deal
July 2, 2024
-
BUSINESS Pfizer Files Hemophilia B Gene Therapy in Japan
July 1, 2024
-
REGULATORY MHLW Sets Up Global Strategy HQ to Bolster Innovation Ecosystem
June 28, 2024
-
BUSINESS Sumitomo Resolved to Revive Business, Optimize Japan Organization: New CEO
June 27, 2024
-
BUSINESS Finnish Pharma Orion Poised for Japan Debut with Reacquisition of Parkinson’s Meds This Year
June 26, 2024
-
BUSINESS BMS Gears Up for Return to Neuroscience with KarXT, Explores Path toward Japan Rollout Too
June 25, 2024
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…